Structure Therapeutics Inc.
GPCR
$21.68
-$0.54-2.43%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -79.88% | -48.88% | -42.39% | -11.83% | -44.85% |
| Total Depreciation and Amortization | 23.42% | 198.88% | 232.53% | 213.51% | 217.14% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,292.63% | 877.78% | -35.61% | 888.36% | -104.18% |
| Change in Net Operating Assets | 16.74% | -119.63% | 397.75% | -132.99% | -74.82% |
| Cash from Operations | -53.25% | -67.83% | 4.19% | -56.23% | -67.82% |
| Capital Expenditure | -93.83% | 98.62% | 16.46% | -123.56% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2,073.86% | 118.51% | -708.61% | -197.85% | 103.22% |
| Cash from Investing | 2,300.07% | 118.39% | -727.45% | -197.65% | 102.89% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 27.81% | -99.80% | -16.07% | 287,772.63% | -99.56% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | -- | -23.74% | 97.96% |
| Cash from Financing | 15.24% | -99.78% | -260.04% | 173,400.67% | -99.59% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 45.60% | -103.31% | -2,185.58% | 430.37% | -131.83% |